Commanders & Chiefs: Clinical Services C-Suite – Pharmavoice
Publié le
IDDI contributed to the Pharmavoice article: Commanders & Chiefs: Clinical Services C-Suite, February, 2021 CROs and other clinical services companies…
Publié le
IDDI contributed to the Pharmavoice article: Commanders & Chiefs: Clinical Services C-Suite, February, 2021 CROs and other clinical services companies…
Publié le
Learn on history of bias and randomization in oncology clinical trials and how to think about what constitutes persuasive evidence…
Publié le
Improvements in the treatment of patients with cancer largely depend on clinical trials comparing a new intervention with a previous…
Publié le
IDDI Complimentary Webinar on characteristics of Covid-19 trials and impact of the pandemic on clinical trials The current SARS-CoV-2-induced…
Publié le
IDDI Complimentary Webinar on the need for integration of biomarker and IVD validation in clinical development Drug development in many…
Publié le
IDDI Complimentary Webinar on Immuno-Oncology Immuno-oncology is a buoyant field of research, with recently developed drugs showing unprecedented response rates…
Publié le
What should companies look for when selecting a CRO clinicalpartner? Just one in ten drug candidates are successful in clinical…
Publié le
The COVID-19 pandemic has a major impact on the conduct of most on-going clinical trials, in particular on the treatment…
Publié le
IMPACT OF COVID-19 on Clinical Trials: LEARN ON OPERATIONAL CHALLENGES TO CONSIDER, ESPECIALLY RELATED TO MISSING DATA AND PROTOCOL DEVIATIONS …
Publié le
Insight on the pharma and biopharma trends impacting CROs, Outsourcing in today’s market, and advances in clinical research. READ IDDI…